amodiaquine has been researched along with Parasitemia in 75 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Parasitemia: The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of acute uncomplicated falciparum malaria during pregnancy." | 9.20 | A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy. ( Aboderin, O; Badejoko, O; Fatusi, A; Loto, O; Ogunniyi, S; Ukah, M, 2015) |
| " The objective was to assess the efficacy and safety of repeated administrations of two fixed-dose presentations of ACT--artesunate plus amodiaquine (ASAQ) and artemether-lumefantrine (AL)--in subsequent episodes of Plasmodium falciparum malaria." | 9.15 | Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. ( Barry, A; Cissé, B; Faye, B; Gaye, O; Gueye, A; Lameyre, V; Ndiaye, D; Ndiaye, I; Ndiaye, JL; Tchania, C; Tine, R, 2011) |
| "The treatment efficacy and effects of artemether-lumefantrine (AL) and amodiaquine-sulfalene-pyrimethamine (ASP) on gametocyte carriage were evaluated in 181 children < or = 10 years of age with uncomplicated Plasmodium falciparum malaria randomized to receive either drug combination." | 9.12 | Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. ( Adedeji, AA; Fateye, BA; Fehintola, FA; Folarin, OA; Gbotosho, GO; Happi, CT; Sowunmi, A; Tambo, E, 2007) |
| "The Angolan government recommends three artemisinin-based combinations for the treatment of uncomplicated Plasmodium falciparum malaria: artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ), and dihydroartemisinin-piperaquine (DP)." | 7.88 | Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. ( Andrade, BN; Davlantes, E; Dimbu, PR; Dos Santos Souza, S; Félix, J; Ferreira, CM; Florinda Joao, M; Fortes, F; Halsey, ES; Martins, JF; Mbounga, E; Owens, C; Plucinski, MM; Pode, D; Sanhangala, E; Talundzic, E; Udhayakumar, V; Wiesner, L, 2018) |
| "falciparum malaria was compared with that of CQ, each drug being given at 10 mg/kg per day for 3 days (days 0, 1 and 2)." | 6.70 | Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. ( Adedeji, AA; Ayede, AI; Falade, AG; Falade, CO; Happi, TC; Ndikum, VN; Oduola, AM; Sowunmi, A; Sowunmi, CO, 2001) |
| " Adverse events were documented in less than 2% of participants for both drugs." | 5.62 | In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018. ( Aide, P; Bassat, Q; Candrinho, B; Carvalho, E; Chidimatembue, A; Enosse, S; Halsey, ES; Lucchi, N; Macete, E; Mayor, A; Moriarty, LF; Nhacolo, A; Nhama, A; Nhamússua, L; Saifodine, A; Salvador, C; Svigel, SS; Zulliger, R, 2021) |
| "To compare the artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of acute uncomplicated falciparum malaria during pregnancy." | 5.20 | A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy. ( Aboderin, O; Badejoko, O; Fatusi, A; Loto, O; Ogunniyi, S; Ukah, M, 2015) |
| " The objective was to assess the efficacy and safety of repeated administrations of two fixed-dose presentations of ACT--artesunate plus amodiaquine (ASAQ) and artemether-lumefantrine (AL)--in subsequent episodes of Plasmodium falciparum malaria." | 5.15 | Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. ( Barry, A; Cissé, B; Faye, B; Gaye, O; Gueye, A; Lameyre, V; Ndiaye, D; Ndiaye, I; Ndiaye, JL; Tchania, C; Tine, R, 2011) |
| "Artesunate (AS) plus amodiaquine (AQ) is one artemisinin-based combination (ACT) recommended by the WHO for treating Plasmodium falciparum malaria." | 5.14 | The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. ( Diarra, A; Gansané, A; Kiechel, JR; Konaté, AT; Morgan, CC; Olliaro, PL; Ouédraogo, A; Sirima, SB; Taylor, WR; Tiono, AB, 2009) |
| "The use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) is threatened by the spread of resistance to SP." | 5.13 | A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. ( Affipunguh, PK; Bruce, J; Chandramohan, D; Clerk, CA; Greenwood, B; Hodgson, A; Mensah, N, 2008) |
| "The treatment efficacy and effects of artemether-lumefantrine (AL) and amodiaquine-sulfalene-pyrimethamine (ASP) on gametocyte carriage were evaluated in 181 children < or = 10 years of age with uncomplicated Plasmodium falciparum malaria randomized to receive either drug combination." | 5.12 | Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. ( Adedeji, AA; Fateye, BA; Fehintola, FA; Folarin, OA; Gbotosho, GO; Happi, CT; Sowunmi, A; Tambo, E, 2007) |
| " In order to investigate the latter, we conducted a randomized clinical trial testing the AR plus amodiaquine (AQ) combination for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso." | 5.11 | A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. ( Barennes, H; Koussoubé-Balima, T; Nagot, N; Ouedraogo, A; Sanou, T; Valea, I; Yé, S, 2004) |
| "The study examined the efficacy of chloroquine (CQ), amodiaquine (AQ) and sulphadoxine-pyrimethamine (SP) for the treatment of uncomplicated Plasmodium falciparum malaria in Ghana." | 5.11 | A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. ( Amankwa, J; Ansah, NA; Ansah, P; Anto, F; Anyorigiya, T; Atuguba, F; Hodgson, A; Mumuni, G; Oduro, AR, 2005) |
| " The authors recommend that the treatment to be used in Abie must be firstly amodiaquine followed by sulfadoxine-pyrimethamine in cases where there is persistent asymptomatic parasitemia." | 5.11 | [Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Côte-d'Ivoire]. ( Adjetey, TA; Affoumou, GB; Barro-Kiki, P; Kone, M; Loukou, DD; Menan, EI; Nebavi, NG; Yavo, W, 2005) |
| "We evaluated gametocyte carriage and intensities of gametocytaemia in 710 children presenting with acute, symptomatic, uncomplicated Plasmodium falciparum malaria who were treated with various antimalarial drug regimens: chloroquine (CQ); chloroquine plus chlorpheniramine, a histamine H1 receptor antagonist that reverses CQ resistance in P." | 5.10 | Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. ( Fateye, BA; Sowunmi, A, 2003) |
| "We conducted two randomized clinical trials to determine the in vivo efficacy of amodiaquine and sulfadoxine/pyrimethamine in treating Plasmodium falciparum malaria." | 5.09 | In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. ( Ashruf, G; Bennebroek, J; Gikunda, S; Gorissen, E; Kager, PA; Lamboo, M; Mbaruku, G, 2000) |
| "In a prospective longitudinal in vivo study, neutrophil rates were compared with malaria carriage after treatment with different ACTs: Artemether - lumefantrine (AL), Artesunate - amodiaquine (ASAQ), Dihydroartemisinin - piperaquine (DP) or Pyronaridine artesunate (PA)." | 4.31 | Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa. ( Arama, C; Beavogui, AH; Dicko, A; Djimde, A; Djimde, M; Fofana, B; Kayentao, K; Mens, PF; Ouedraogo, JB; Sagara, I; Schallig, HD; Sirima, SB; Tshiongo, JK, 2023) |
| " Whether the addition of azithromycin to the monthly sulfadoxine-pyrimethamine plus amodiaquine used for seasonal malaria chemoprevention could reduce mortality and morbidity among African children was unclear." | 3.91 | Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention. ( Barry, A; Cairns, M; Chandramohan, D; Coumare, S; Diarra, M; Dicko, A; Doumbo, O; Greenwood, B; Kuepfer, I; Milligan, P; Nikiema, F; Ouedraogo, JB; Sagara, I; Tapily, A; Thera, I; Tinto, H; Traore, A; Yerbanga, S; Zongo, I, 2019) |
| "The Angolan government recommends three artemisinin-based combinations for the treatment of uncomplicated Plasmodium falciparum malaria: artemether-lumefantrine (AL), artesunate-amodiaquine (ASAQ), and dihydroartemisinin-piperaquine (DP)." | 3.88 | Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. ( Andrade, BN; Davlantes, E; Dimbu, PR; Dos Santos Souza, S; Félix, J; Ferreira, CM; Florinda Joao, M; Fortes, F; Halsey, ES; Martins, JF; Mbounga, E; Owens, C; Plucinski, MM; Pode, D; Sanhangala, E; Talundzic, E; Udhayakumar, V; Wiesner, L, 2018) |
| " This study reports the results of therapeutic efficacy studies conducted on artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Togo, between 2005 and 2009." | 3.78 | Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009. ( Agbo, YM; Barrette, A; Bogreau, H; Dorkenoo, MA; Kutoati, S; Morgah, K; Sodahlon, YK, 2012) |
| " Adverse events and clinical and parasitological outcomes were recorded." | 2.73 | A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. ( D'Alessandro, U; Fanello, CI; Karema, C; Ngamije, D; van Doren, W; Van Overmeir, C, 2007) |
| "Nearly all recurrences were due to new infections." | 2.73 | Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. ( Dokomajilar, C; Dorsey, G; Guiguemde, RT; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Tinto, H; Zongo, I, 2007) |
| "The main adverse events were gastrointestinal disorders (2." | 2.73 | Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria. ( Brasseur, P; Cisse, M; Diouf, AM; Faye, B; Gaye, O; Kuété, T; Lameyre, V; Ndiaye, JL; Same-Ekobo, A; Seck, PA, 2008) |
| "Amodiaquine is a common partner drug in different malaria combination therapies used or investigated in sub-Saharan Africa, but data on its efficacy as a single drug are scarce." | 2.73 | Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso. ( Coulibaly, B; Mandi, G; Meissner, P; Mockenhaupt, FP; Müller, O, 2008) |
| "falciparum malaria was compared with that of CQ, each drug being given at 10 mg/kg per day for 3 days (days 0, 1 and 2)." | 2.70 | Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. ( Adedeji, AA; Ayede, AI; Falade, AG; Falade, CO; Happi, TC; Ndikum, VN; Oduola, AM; Sowunmi, A; Sowunmi, CO, 2001) |
| " Adverse events were documented in less than 2% of participants for both drugs." | 1.62 | In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018. ( Aide, P; Bassat, Q; Candrinho, B; Carvalho, E; Chidimatembue, A; Enosse, S; Halsey, ES; Lucchi, N; Macete, E; Mayor, A; Moriarty, LF; Nhacolo, A; Nhama, A; Nhamússua, L; Saifodine, A; Salvador, C; Svigel, SS; Zulliger, R, 2021) |
| "Artemisinin resistance, a long parasite clearance half-life in response to artemisinin, has been described in patients with Plasmodium falciparum malaria in southeast Asia." | 1.39 | Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. ( Anderson, JM; Chiang, S; Diakite, M; Diakite, SA; Doumbia, S; Doumbouya, M; Fairhurst, RM; Fay, MP; Keita, AS; Konate, DS; Long, CA; Lopera-Mesa, TM; Ndiaye, D; Sa, JM; Stepniewska, K; Traore, K; Zeituni, AE, 2013) |
| " Intermittent preventive treatment for children (IPTc) combined with timely treatment of malaria related febrile illness at home to reduce parasite prevalence and malaria morbidity in children aged between six and 60 months in a coastal community in Ghana." | 1.37 | Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana. ( Ahorlu, CK; Koram, KA; Seake-Kwawu, A; Weiss, MG, 2011) |
| "Recrudescence was detected by a thick blood smear and confirmed by polymerase chain reaction." | 1.35 | Some features of primary and recrudescent amodiaquine-resistant Plasmodium falciparum infections in Nigerian children. ( Balogun, ST; Gbotosho, GO; Happi, CT; Sowunmi, A, 2008) |
| "Falciparum Malaria is hyperendemic in southern Nigeria and chloroquine resistance is an increasing problem." | 1.33 | Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine. ( Göbels, K; Graupner, J; Grobusch, MP; Häussinger, D; Lund, A; Richter, J, 2005) |
| "Amodiaquine was 3." | 1.31 | In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar. ( Ariey, F; Duchemin, JB; Harisoa, JL; Mauclere, P; Pietra, V; Rabarijaona, LP; Raharimalala, LA; Rakotomanana, F; Ranaivo, L; Randrianarivelojosia, M; Robert, V, 2002) |
| "Amodiaquine was shown to be more effective than chloroquine in clinical response and ridding patients of parasites: adequate clinical response was significantly higher with amodiaquine than chloroquine [100% (27/27) versus 45% (9/20), p < 0." | 1.31 | [Evaluation of efficacy and tolerance of amodiaquine versus chloroquine in the treatment of uncomplicated malaria outbreak in children of Gabon]. ( Bouyou Akotet, M; Guiyedi, V; Koko, J; Kombila, M; Mabika Manfoumbi, M; Matsiégui, PB; Traoré, B, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (4.00) | 18.2507 |
| 2000's | 37 (49.33) | 29.6817 |
| 2010's | 31 (41.33) | 24.3611 |
| 2020's | 4 (5.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cross, RM | 1 |
| Flanigan, DL | 1 |
| Monastyrskyi, A | 1 |
| LaCrue, AN | 1 |
| Sáenz, FE | 1 |
| Maignan, JR | 1 |
| Mutka, TS | 1 |
| White, KL | 1 |
| Shackleford, DM | 1 |
| Bathurst, I | 1 |
| Fronczek, FR | 1 |
| Wojtas, L | 1 |
| Guida, WC | 1 |
| Charman, SA | 1 |
| Burrows, JN | 1 |
| Kyle, DE | 1 |
| Manetsch, R | 1 |
| Nhama, A | 1 |
| Nhamússua, L | 1 |
| Macete, E | 1 |
| Bassat, Q | 1 |
| Salvador, C | 1 |
| Enosse, S | 1 |
| Candrinho, B | 1 |
| Carvalho, E | 1 |
| Nhacolo, A | 1 |
| Chidimatembue, A | 1 |
| Saifodine, A | 1 |
| Zulliger, R | 1 |
| Lucchi, N | 1 |
| Svigel, SS | 1 |
| Moriarty, LF | 1 |
| Halsey, ES | 2 |
| Mayor, A | 1 |
| Aide, P | 1 |
| Pembet Singana, B | 1 |
| Casimiro, PN | 1 |
| Matondo Diassivi, B | 1 |
| Kobawila, SC | 1 |
| Youndouka, JM | 1 |
| Basco, LK | 3 |
| Ringwald, P | 1 |
| Briolant, S | 1 |
| Ndounga, M | 2 |
| Djimde, M | 1 |
| Kayentao, K | 1 |
| Tshiongo, JK | 1 |
| Fofana, B | 1 |
| Arama, C | 1 |
| Sirima, SB | 3 |
| Ouedraogo, JB | 4 |
| Beavogui, AH | 1 |
| Sagara, I | 2 |
| Dicko, A | 3 |
| Mens, PF | 1 |
| Schallig, HD | 1 |
| Djimde, A | 2 |
| Akano, K | 5 |
| Fatunmbi, B | 4 |
| Ntadom, G | 6 |
| Ayede, AI | 4 |
| Aderoyeje, T | 4 |
| Bakre, A | 1 |
| Alebiosu, OT | 1 |
| Akpoborie, O | 1 |
| Okafor, C | 1 |
| Gbotosho, GO | 9 |
| Folarin, OA | 5 |
| Ebenebe, JC | 2 |
| Ambe, J | 2 |
| Wammanda, R | 2 |
| Jiya, N | 2 |
| Finomo, F | 2 |
| Emechebe, G | 2 |
| Mokuolu, O | 2 |
| Agomo, C | 4 |
| Oguche, S | 4 |
| Happi, C | 3 |
| Sowunmi, A | 17 |
| Esu, EB | 1 |
| Oringanje, C | 1 |
| Meremikwu, MM | 1 |
| Ayede, A | 1 |
| Okafor, H | 1 |
| Watila, I | 2 |
| Meremikwu, M | 2 |
| Ogala, W | 2 |
| Agomo, P | 2 |
| Adowoye, E | 1 |
| Gbotosho, G | 1 |
| Folarin, O | 1 |
| Valverde, EA | 1 |
| Romero, AH | 1 |
| Acosta, ME | 1 |
| Gamboa, N | 1 |
| Henriques, G | 1 |
| Rodrigues, JR | 1 |
| Ciangherotti, C | 1 |
| López, SE | 1 |
| Davlantes, E | 1 |
| Dimbu, PR | 1 |
| Ferreira, CM | 1 |
| Florinda Joao, M | 1 |
| Pode, D | 1 |
| Félix, J | 1 |
| Sanhangala, E | 1 |
| Andrade, BN | 1 |
| Dos Santos Souza, S | 1 |
| Talundzic, E | 1 |
| Udhayakumar, V | 1 |
| Owens, C | 1 |
| Mbounga, E | 1 |
| Wiesner, L | 1 |
| Martins, JF | 1 |
| Fortes, F | 1 |
| Plucinski, MM | 1 |
| Useh, F | 1 |
| Oyibo, W | 1 |
| Abdulkadir, M | 1 |
| Ezeigwe, NM | 1 |
| Munyangi, J | 1 |
| Cornet-Vernet, L | 1 |
| Idumbo, M | 1 |
| Lu, C | 1 |
| Lutgen, P | 1 |
| Perronne, C | 1 |
| Ngombe, N | 1 |
| Bianga, J | 1 |
| Mupenda, B | 1 |
| Lalukala, P | 1 |
| Mergeai, G | 1 |
| Mumba, D | 1 |
| Towler, M | 1 |
| Weathers, P | 1 |
| Chandramohan, D | 3 |
| Zongo, I | 2 |
| Cairns, M | 1 |
| Kuepfer, I | 1 |
| Diarra, M | 1 |
| Barry, A | 3 |
| Tapily, A | 1 |
| Nikiema, F | 1 |
| Yerbanga, S | 1 |
| Coumare, S | 1 |
| Thera, I | 1 |
| Traore, A | 1 |
| Milligan, P | 1 |
| Tinto, H | 3 |
| Doumbo, O | 1 |
| Greenwood, B | 3 |
| Lopera-Mesa, TM | 1 |
| Doumbia, S | 1 |
| Chiang, S | 1 |
| Zeituni, AE | 1 |
| Konate, DS | 1 |
| Doumbouya, M | 1 |
| Keita, AS | 1 |
| Stepniewska, K | 1 |
| Traore, K | 1 |
| Diakite, SA | 1 |
| Ndiaye, D | 2 |
| Sa, JM | 1 |
| Anderson, JM | 1 |
| Fay, MP | 1 |
| Long, CA | 1 |
| Diakite, M | 1 |
| Fairhurst, RM | 1 |
| Ojurongbe, O | 1 |
| Lawal, OA | 1 |
| Abiodun, OO | 1 |
| Okeniyi, JA | 1 |
| Oyeniyi, AJ | 1 |
| Oyelami, OA | 1 |
| Zwang, J | 1 |
| Dorsey, G | 3 |
| Mårtensson, A | 1 |
| d'Alessandro, U | 2 |
| Ndiaye, JL | 4 |
| Karema, C | 2 |
| Brasseur, P | 2 |
| Olliaro, P | 2 |
| Onyamboko, MA | 1 |
| Fanello, CI | 2 |
| Wongsaen, K | 1 |
| Tarning, J | 1 |
| Cheah, PY | 1 |
| Tshefu, KA | 1 |
| Dondorp, AM | 1 |
| Nosten, F | 1 |
| White, NJ | 1 |
| Day, NP | 1 |
| Okafor, HU | 1 |
| Banjo, O | 1 |
| Okuboyejo, T | 2 |
| Ogunrinde, G | 1 |
| Odey, F | 1 |
| Aina, O | 1 |
| Sofola, T | 1 |
| Ukah, M | 1 |
| Badejoko, O | 1 |
| Ogunniyi, S | 1 |
| Loto, O | 1 |
| Aboderin, O | 1 |
| Fatusi, A | 1 |
| Sondo, P | 1 |
| Derra, K | 1 |
| Diallo Nakanabo, S | 1 |
| Tarnagda, Z | 1 |
| Kazienga, A | 1 |
| Zampa, O | 1 |
| Valéa, I | 2 |
| Sorgho, H | 1 |
| Owusu-Dabo, E | 1 |
| Guiguemdé, TR | 1 |
| Adewoye, EO | 2 |
| Siqueira, AM | 1 |
| Alencar, AC | 1 |
| Melo, GC | 1 |
| Magalhaes, BL | 1 |
| Machado, K | 1 |
| Alencar Filho, AC | 1 |
| Kuehn, A | 1 |
| Marques, MM | 1 |
| Manso, MC | 1 |
| Felger, I | 1 |
| Vieira, JL | 1 |
| Lameyre, V | 3 |
| Daniel-Ribeiro, CT | 1 |
| Lacerda, MV | 1 |
| Happi, CT | 7 |
| Carmona-Fonseca, J | 2 |
| Arango, E | 1 |
| Blair, S | 1 |
| Clerk, CA | 1 |
| Bruce, J | 1 |
| Affipunguh, PK | 1 |
| Mensah, N | 1 |
| Hodgson, A | 2 |
| Balogun, ST | 2 |
| Hasugian, AR | 1 |
| Tjitra, E | 1 |
| Ratcliff, A | 1 |
| Siswantoro, H | 1 |
| Kenangalem, E | 1 |
| Wuwung, RM | 1 |
| Purba, HL | 1 |
| Piera, KA | 1 |
| Chalfien, F | 1 |
| Marfurt, J | 1 |
| Penttinen, PM | 1 |
| Russell, B | 1 |
| Anstey, NM | 1 |
| Price, RN | 1 |
| Tiono, AB | 1 |
| Gansané, A | 1 |
| Diarra, A | 1 |
| Ouédraogo, A | 2 |
| Konaté, AT | 1 |
| Kiechel, JR | 1 |
| Morgan, CC | 1 |
| Olliaro, PL | 1 |
| Taylor, WR | 2 |
| Kiboi, DM | 1 |
| Irungu, BN | 1 |
| Langat, B | 1 |
| Wittlin, S | 1 |
| Brun, R | 1 |
| Chollet, J | 1 |
| Abiodun, O | 1 |
| Nganga, JK | 1 |
| Nyambati, VC | 1 |
| Rukunga, GM | 1 |
| Bell, A | 1 |
| Nzila, A | 1 |
| Ahorlu, CK | 2 |
| Koram, KA | 2 |
| Seakey, AK | 1 |
| Weiss, MG | 2 |
| Whegang, SY | 1 |
| Tahar, R | 1 |
| Foumane, VN | 1 |
| Soula, G | 1 |
| Gwét, H | 1 |
| Thalabard, JC | 1 |
| Bousema, T | 1 |
| Okell, L | 1 |
| Shekalaghe, S | 1 |
| Griffin, JT | 1 |
| Omar, S | 1 |
| Sawa, P | 1 |
| Sutherland, C | 1 |
| Sauerwein, R | 1 |
| Ghani, AC | 1 |
| Drakeley, C | 1 |
| Willcox, ML | 1 |
| Graz, B | 1 |
| Diakite, C | 1 |
| Falquet, J | 1 |
| Dackouo, F | 1 |
| Sidibe, O | 1 |
| Giani, S | 1 |
| Diallo, D | 1 |
| Michael, OS | 1 |
| Oduola, AM | 3 |
| Seake-Kwawu, A | 1 |
| Okuboyejo, TM | 2 |
| Faye, B | 3 |
| Gueye, A | 1 |
| Tine, R | 1 |
| Tchania, C | 1 |
| Ndiaye, I | 1 |
| Cissé, B | 1 |
| Gaye, O | 3 |
| Dicko, M | 1 |
| Diallo, AI | 1 |
| Tembine, I | 1 |
| Dicko, Y | 1 |
| Dara, N | 1 |
| Sidibe, Y | 1 |
| Santara, G | 1 |
| Conaré, T | 1 |
| Cousens, S | 1 |
| Milligan, PJ | 1 |
| Diallo, DA | 1 |
| Doumbo, OK | 1 |
| Tine, RC | 1 |
| Ndour, CT | 1 |
| Ndiaye, M | 1 |
| Bassene, C | 1 |
| Magnussen, P | 1 |
| Bygbjerg, IC | 1 |
| Sylla, K | 1 |
| Ndour, JD | 1 |
| Arango, EM | 1 |
| Upegui, YA | 1 |
| Espié, E | 1 |
| Lima, A | 1 |
| Atua, B | 1 |
| Dhorda, M | 1 |
| Flévaud, L | 1 |
| Sompwe, EM | 1 |
| Palma Urrutia, PP | 1 |
| Guerin, PJ | 1 |
| Dorkenoo, MA | 1 |
| Barrette, A | 1 |
| Agbo, YM | 1 |
| Bogreau, H | 1 |
| Kutoati, S | 1 |
| Sodahlon, YK | 1 |
| Morgah, K | 1 |
| Randrianarivelojosia, M | 1 |
| Harisoa, JL | 1 |
| Rabarijaona, LP | 1 |
| Raharimalala, LA | 1 |
| Ranaivo, L | 1 |
| Pietra, V | 2 |
| Duchemin, JB | 1 |
| Rakotomanana, F | 1 |
| Robert, V | 1 |
| Mauclere, P | 1 |
| Ariey, F | 1 |
| Fateye, BA | 5 |
| Barennes, H | 1 |
| Nagot, N | 1 |
| Koussoubé-Balima, T | 1 |
| Sanou, T | 1 |
| Yé, S | 1 |
| Adedeji, AA | 5 |
| Fehintola, FA | 3 |
| Happi, TC | 3 |
| Babalola, CP | 1 |
| Oduro, AR | 1 |
| Anyorigiya, T | 1 |
| Ansah, P | 1 |
| Anto, F | 1 |
| Ansah, NA | 1 |
| Atuguba, F | 1 |
| Mumuni, G | 1 |
| Amankwa, J | 1 |
| Graupner, J | 1 |
| Göbels, K | 1 |
| Grobusch, MP | 1 |
| Lund, A | 1 |
| Richter, J | 1 |
| Häussinger, D | 1 |
| Tambo, E | 2 |
| Adjetey, TA | 2 |
| Affoumou, GB | 1 |
| Loukou, DD | 1 |
| Nebavi, NG | 2 |
| Barro-Kiki, P | 1 |
| Menan, EI | 2 |
| Yavo, W | 2 |
| Kone, M | 3 |
| Patrick Kachur, S | 1 |
| Schulden, J | 1 |
| Goodman, CA | 1 |
| Kassala, H | 1 |
| Elling, BF | 1 |
| Khatib, RA | 1 |
| Causer, LM | 1 |
| Mkikima, S | 1 |
| Abdulla, S | 1 |
| Bloland, PB | 1 |
| Zurovac, D | 1 |
| Midia, B | 1 |
| Ochola, SA | 1 |
| English, M | 1 |
| Snow, RW | 1 |
| Grandesso, F | 1 |
| Hagerman, A | 1 |
| Kamara, S | 1 |
| Lam, E | 1 |
| Checchi, F | 1 |
| Balkan, S | 1 |
| Scollo, G | 1 |
| Durand, R | 1 |
| Guthmann, JP | 1 |
| van Doren, W | 1 |
| Van Overmeir, C | 1 |
| Ngamije, D | 1 |
| Holmgren, G | 1 |
| Björkman, A | 1 |
| Gil, JP | 1 |
| Ibrahium, AM | 1 |
| Kheir, MM | 1 |
| Osman, ME | 1 |
| Khalil, IF | 1 |
| Alifrangis, M | 1 |
| Elmardi, KA | 1 |
| Malik, EM | 1 |
| Adam, I | 1 |
| Rouamba, N | 1 |
| Dokomajilar, C | 2 |
| Guiguemde, RT | 1 |
| Rosenthal, PJ | 2 |
| Osorio, L | 1 |
| Gonzalez, I | 1 |
| Staedke, S | 1 |
| Clark, TD | 1 |
| Njama-Meya, D | 1 |
| Nzarubara, B | 1 |
| Maiteki-Sebuguzi, C | 1 |
| Kamya, MR | 1 |
| Ehrhardt, S | 1 |
| Eggelte, TA | 1 |
| Kaiser, S | 1 |
| Adjei, L | 1 |
| Burchard, GD | 1 |
| Anemana, SD | 1 |
| Bienzle, U | 1 |
| Mockenhaupt, FP | 2 |
| Diouf, AM | 1 |
| Kuété, T | 1 |
| Cisse, M | 1 |
| Seck, PA | 1 |
| Same-Ekobo, A | 1 |
| Mandi, G | 1 |
| Coulibaly, B | 1 |
| Meissner, P | 1 |
| Müller, O | 1 |
| Del Nero, L | 1 |
| Lamizana, L | 1 |
| Nebié, I | 1 |
| le Hesran, JY | 1 |
| Boudin, C | 1 |
| Cot, M | 1 |
| Personne, P | 1 |
| Chambon, R | 1 |
| Foumane, V | 1 |
| Verhave, JP | 1 |
| de Vries, C | 1 |
| al-Yaman, F | 1 |
| Genton, B | 1 |
| Mokela, D | 1 |
| Narara, A | 1 |
| Raiko, A | 1 |
| Alpers, MP | 1 |
| Adou-Bryn, KD | 1 |
| Kouassi, D | 1 |
| Ouhon, J | 1 |
| Assoumou, A | 1 |
| Gorissen, E | 1 |
| Ashruf, G | 1 |
| Lamboo, M | 1 |
| Bennebroek, J | 1 |
| Gikunda, S | 1 |
| Mbaruku, G | 1 |
| Kager, PA | 1 |
| Collins, WE | 1 |
| Sullivan, JS | 1 |
| Fryauff, DJ | 1 |
| Kendall, J | 1 |
| Jennings, V | 1 |
| Galland, GG | 1 |
| Morris, CL | 1 |
| Falade, AG | 1 |
| Ndikum, VN | 1 |
| Sowunmi, CO | 1 |
| Falade, CO | 1 |
| Guiyedi, V | 1 |
| Koko, J | 1 |
| Bouyou Akotet, M | 1 |
| Mabika Manfoumbi, M | 1 |
| Matsiégui, PB | 1 |
| Traoré, B | 1 |
| Kombila, M | 1 |
| Barro-Kiki, PC | 1 |
| Nigué, L | 1 |
| Konan, YJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Children: A Multisite Open Label, Two-cohort Clinical Trial in Mozambique[NCT04370977] | Phase 4 | 630 participants (Actual) | Interventional | 2018-03-21 | Completed | ||
| Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Cameroon[NCT06173206] | Phase 3 | 900 participants (Anticipated) | Interventional | 2024-03-15 | Not yet recruiting | ||
| Randomized, Double-blind, Placebo-controlled, Multicenter, Multi-arm, Phase II Trial of Novel Agents for the Treatment of Mild to Moderate COVID-19 Positive Outpatients[NCT04530617] | Phase 2 | 246 participants (Actual) | Interventional | 2020-10-05 | Terminated (stopped due to Results from the interim analysis) | ||
| A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children[NCT02211729] | Phase 3 | 22,090 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| Artemether-Lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in Mali[NCT02645604] | 154 participants (Actual) | Observational | 2016-01-01 | Completed | |||
| Studies of Innate and Acquired Resistance to P. Falciparum Malaria in Mali[NCT00669084] | 1,718 participants (Actual) | Observational | 2008-04-21 | Completed | |||
| Pharmacovigilance for Artemisinin-based Combination Treatments in Africa[NCT01232530] | 3,176 participants (Actual) | Observational | 2010-06-30 | Completed | |||
| A Randomised Comparative Study to Assess the Efficacy and Tolerability of Blood Schizonticidal Treatments With Artesunate Amodiaquine Winthrop® / Coarsucam (ASAQ) Versus Chloroquine (CQ) for Uncomplicated Plasmodium Vivax Monoinfection Malaria[NCT01378286] | Phase 3 | 380 participants (Actual) | Interventional | 2012-01-31 | Completed | ||
| Efficacy of Sulphadoxine-pyrimethamine and Amodiaquine Alone or in Combination as Intermittent Preventive Treatment in Pregnancy in the Kassena-Nankana District of Ghana: a Randomized Controlled Trial[NCT00146783] | Phase 2/Phase 3 | 3,642 participants (Actual) | Interventional | 2004-06-30 | Completed | ||
| Exploring the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children in the Pakro Sub District of Ghana[NCT04167566] | 5,000 participants (Actual) | Interventional | 2017-07-01 | Completed | |||
| Assessment of Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa[NCT02974348] | Phase 3 | 300 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| Evaluation of the Efficacy and Safety of Primaquine for Clearance of Gametocytes in Uncomplicated Falciparum Malaria in Uganda[NCT01365598] | Phase 3 | 468 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
| Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children in the Pakro Sub District of Ghana[NCT04301531] | 5,861 participants (Actual) | Interventional | 2020-03-01 | Completed | |||
| A Randomized Study to Compare Artesunate + Amiodaquine Versus Artemether + Lumefantrine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Occurring During 2 Years in a Cohort in Senegal[NCT00540410] | Phase 4 | 366 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African Children[NCT00738946] | 6,000 participants (Anticipated) | Interventional | 2008-08-31 | Completed | |||
| Efficacy of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Childhood Plasmodium Falciparum Malaria in Pweto, Democratic Republic of Congo, 2008[NCT01567423] | 301 participants (Actual) | Interventional | 2008-04-30 | Completed | |||
| Longitudinal Comparison of Combination Antimalarial Therapies in Ugandan Children: Evaluation of Safety, Tolerability, and Efficacy[NCT00123552] | Phase 3 | 601 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amodiaquine and Parasitemia
| Article | Year |
|---|---|
Intermittent preventive treatment for malaria in infants.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Bias; Confidence Intervals; Di | 2021 |
Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Humans; Kin | 2014 |
38 trials available for amodiaquine and Parasitemia
| Article | Year |
|---|---|
Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisia; Artemisia annua; Artemisinins; Child; Doub | 2019 |
Efficacy of artemisinin combination therapy for the treatment of uncomplicated falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, P | 2013 |
Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschoo | 2014 |
Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.
Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, | 2014 |
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisini | 2015 |
Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Brazil; Child; Child, Preschool; | 2017 |
[Gametocytemia in falciparum malaria treated with amodiaquine or artesunate].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; | 2008 |
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Therapy, Comb | 2008 |
The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Burkina Faso; Child, Preschool; Drug Combinations | 2009 |
Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Caregivers; Child, Preschool; | 2009 |
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
Topics: Administration, Oral; Amodiaquine; Antimalarials; Artemisinins; Cameroon; Child, Preschool; Drug Adm | 2010 |
Is parasite clearance clinically important after malaria treatment in a high transmission area? A 3-month follow-up of home-based management with herbal medicine or ACT.
Topics: Adolescent; Amodiaquine; Antimalarials; Argemone; Artemisinins; Child; Child, Preschool; Drug Combin | 2011 |
Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; C | 2010 |
Oral artesunate-amodiaquine and artemether-lumefantrine in the treatment of uncomplicated hyperparasitaemic Plasmodium falciparum malaria in children.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, P | 2012 |
Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Arte | 2011 |
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
Topics: Amodiaquine; Anemia; Antimalarials; Body Weight; Child, Preschool; Drug Administration Schedule; Dru | 2011 |
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; C | 2011 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Prescho | 2012 |
Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschoo | 2012 |
Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combina | 2003 |
A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Bl | 2004 |
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children.
Topics: Amodiaquine; Animals; Antimalarials; Carrier State; Child; Child, Preschool; Chloroquine; Chlorpheni | 2004 |
Plasmodium falciparum hyperparasitaemia in children. Risk factors, treatment outcomes, and gametocytaemia following treatment.
Topics: Age Factors; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combina | 2004 |
A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
Topics: Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Female; Fever; Ghana; | 2005 |
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Com | 2005 |
[Evaluation of the therapeutic efficacy of amodiaquine versus chloroquine in the treatment of uncomplicated malaria in Abie, Côte-d'Ivoire].
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Cote d'Ivoire; Drug Combinations | 2005 |
A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschoo | 2007 |
Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya.
Topics: Amodiaquine; Animals; Antimalarials; Child; Drug Resistance, Multiple; Follow-Up Studies; Gene Ampli | 2006 |
Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Comb | 2007 |
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; C | 2007 |
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Bone Marrow Diseas | 2007 |
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesu | 2007 |
Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; | 2007 |
Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Cameroon; Child; C | 2008 |
Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso.
Topics: Amino Acid Substitution; Amodiaquine; Animals; Antimalarials; Burkina Faso; Child, Preschool; DNA, P | 2008 |
[Clinical trial of amodiaquine in the community of Attécoubé (Abidjan, Côte d'Ivoire)(May-December 1955)].
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Cote d'Ivoire; Female; Humans; Malaria, Falciparum; M | 2000 |
In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Drug Resistance, Microbial; Female; Fe | 2000 |
Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
Topics: Age Factors; Amodiaquine; Analysis of Variance; Antimalarials; Child; Child, Preschool; Chloroquine; | 2001 |
35 other studies available for amodiaquine and Parasitemia
| Article | Year |
|---|---|
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Paras | 2014 |
In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschoo | 2021 |
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child | 2022 |
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa.
Topics: Africa; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesun | 2023 |
Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria.
Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, | 2019 |
Anaemia following Artemisinin-Based Combination Treatments of Uncomplicated Plasmodium falciparum Malaria in Children: Temporal Patterns of Haematocrit and the Use of Uncomplicated Hyperparasitaemia as a Model for Evaluating Late-Appearing Anaemia.
Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; | 2017 |
Synthesis, β-hematin inhibition studies and antimalarial evaluation of new dehydroxy isoquine derivatives against Plasmodium berghei: A promising antimalarial agent.
Topics: Aminoquinolines; Amodiaquine; Animals; Antimalarials; Erythrocytes; Humans; Macrophages; Mice; Paras | 2018 |
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Topics: Adolescent; Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisin | 2018 |
Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschoo | 2018 |
Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Azithromycin; Burkina Faso; Child Mortality; Chil | 2019 |
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
Topics: Adaptive Immunity; Adolescent; Amodiaquine; Antibodies, Protozoan; Antimalarials; Artemisinins; Arte | 2013 |
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
Topics: Adaptive Immunity; Adolescent; Amodiaquine; Antibodies, Protozoan; Antimalarials; Artemisinins; Arte | 2013 |
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
Topics: Adaptive Immunity; Adolescent; Amodiaquine; Antibodies, Protozoan; Antimalarials; Artemisinins; Arte | 2013 |
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
Topics: Adaptive Immunity; Adolescent; Amodiaquine; Antibodies, Protozoan; Antimalarials; Artemisinins; Arte | 2013 |
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.
Topics: Adult; Aged; Alleles; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemis | 2016 |
Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.
Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, | 2016 |
Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.
Topics: Administration, Oral; Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child Health Serv | 2017 |
Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine.
Topics: Africa; Amodiaquine; Anemia; Animals; Child; Child, Preschool; Female; Humans; Infant; Kaplan-Meier | 2008 |
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
Topics: Adolescent; Age Distribution; Amodiaquine; Animals; Antimalarials; Chloroquine; Confidence Intervals | 2009 |
Some features of primary and recrudescent amodiaquine-resistant Plasmodium falciparum infections in Nigerian children.
Topics: Acute Disease; Amodiaquine; Animals; Antimalarials; Case-Control Studies; Child; Child, Preschool; D | 2008 |
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Resista | 2009 |
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Art | 2010 |
Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinati | 2011 |
Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinati | 2011 |
Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinati | 2011 |
Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinati | 2011 |
Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.
Topics: Amodiaquine; Analysis of Variance; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemis | 2011 |
Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009.
Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschoo | 2012 |
In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Resistance, Multiple; Humans | 2002 |
Rapid clearance of Plasmodium falciparum hyperparasitaemia after oral amodiaquine treatment in patients with uncomplicated malaria.
Topics: Administration, Oral; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Female; Humans; | 2003 |
Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine.
Topics: Amodiaquine; Animals; Antimalarials; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistan | 2005 |
Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.
Topics: Adult; Amodiaquine; Analgesics, Non-Narcotic; Anemia; Antimalarials; Child, Preschool; Drug Combinat | 2006 |
Microscopy and outpatient malaria case management among older children and adults in Kenya.
Topics: Adolescent; Adult; Ambulatory Care; Amodiaquine; Antimalarials; Case Management; Child; Cross-Sectio | 2006 |
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; F | 2006 |
Large-scale surveillance of Plasmodium falciparum crt(K76T) in northern Ghana.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemisinins; Child; Chloroquine; Drug | 2007 |
Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
Topics: Amodiaquine; Animals; Antimalarials; Burkina Faso; Child; Child, Preschool; Chloroquine; Drug Resist | 1994 |
In-vivo resistance of Plasmodium falciparum to chloroquine and amodiaquine in south Cameroon and age-related efficacy of the drugs.
Topics: Adolescent; Age Factors; Amodiaquine; Animals; Antimalarials; Cameroon; Child; Child, Preschool; Chl | 1997 |
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.
Topics: Acute Disease; Amodiaquine; Animals; Antimalarials; Case-Control Studies; Child; Child, Preschool; C | 1996 |
Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.
Topics: Adaptation, Physiological; Adult; Amodiaquine; Animals; Antimalarials; Aotidae; Child; Chloroquine; | 2000 |
[Evaluation of efficacy and tolerance of amodiaquine versus chloroquine in the treatment of uncomplicated malaria outbreak in children of Gabon].
Topics: Adolescent; Amodiaquine; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Resistance; Femal | 2001 |
[In vivo sensitivity of Plasmodium falciparum to amino-4-quinolines and sulfadoxine pyrimethamine in Agou (Ivory Coast)].
Topics: Adolescent; Aminoquinolines; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Cote d'Iv | 2002 |